TNF Pharmaceuticals Inc (NASDAQ:TNFA) has a beta value of 2.45 and has seen 7.18 million shares traded in the last trading session. The company, currently valued at $1.21M, closed the last trade at $0.44 per share which meant it gained $0.09 on the day or 26.26% during that session. The TNFA stock price is -695.45% off its 52-week high price of $3.50 and 27.27% above the 52-week low of $0.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.96 million shares traded. The 3-month trading volume is 527.83K shares.
TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information
Sporting 26.26% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNFA stock price touched $0.44 or saw a rise of 0.9%. Year-to-date, TNF Pharmaceuticals Inc shares have moved -61.57%, while the 5-day performance has seen it change 24.25%. Over the past 30 days, the shares of TNF Pharmaceuticals Inc (NASDAQ:TNFA) have changed 12.41%. Short interest in the company has seen 0.78 million shares shorted with days to cover at 1.18.
TNF Pharmaceuticals Inc (TNFA) estimates and forecasts
The company’s shares have lost -71.12% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 67.29% over the past 5 years.
TNFA Dividends
TNF Pharmaceuticals Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders
Insiders own 0.59% of the company shares, while shares held by institutions stand at 15.10% with a share float percentage of 15.19%. Investors are also buoyed by the number of investors in a company, with TNF Pharmaceuticals Inc having a total of 26.0 institutions that hold shares in the company.
